Mpox in Children: 3 Cases.
| Autor: | Frantzis I; Departments of Pediatrics., Ungar SP; Division of Pediatric Infectious Diseases, Department of Pediatrics., Soma VL; Division of Pediatric Infectious Diseases, Department of Pediatrics., Knutsen D; Division of Infectious Diseases, Department of Medicine, New York University Grossman School of Medicine, New York, New York., Mazo D; Division of Infectious Diseases, Department of Medicine, New York University Grossman School of Medicine, New York, New York., Zucker J; Medicine, Columbia University Irving Medical Center, New York, New York. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Pediatrics [Pediatrics] 2024 Jan 01; Vol. 153 (2). |
| DOI: | 10.1542/peds.2022-061047 |
| Abstrakt: | Although the 2022 mpox outbreak mostly affected adults, its effect on children and adolescents was also substantial. In this report, we describe the clinical course and treatment of the first 3 known cases of mpox in children in New York City. These cases are instructive because they illustrate various routes of transmission, clinical presentations, and diagnostic challenges that differ from previous reports of mpox in endemic countries and previous mpox outbreaks. Of note is that each of the 3 patients received treatment with tecovirimat under an US Food and Drug Administration expanded access investigational new drug application and improved without exhibiting adverse reactions. (Copyright © 2024 by the American Academy of Pediatrics.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|